Simona Erscoiu *, Doinița Ispas *, D. Duiculescu *
* Simona Erscoiu, Doinița Ispas, D. Duiculescu – Clinica de Boli lnfecțioase și Tropicale Dr. Victor Babeș, București
Abstract
Efavirenz (EFV) a non-nucleoside reverse transcriptase inhibitor was introduced in treatment of HIV infected romanian adults in 1999, used in combination with other protease inhibitors or nucleoside inhibitors. The aim of this study is to evaluate the efficacy and tolerability EFV in combination with other antiretroviral treatment in 35 adults HIV infected, during March 1999 and 2000 (22 naive and 13 pretreated patients).